Skip to main content
FinSpry Logo
FinSpry
ABBV logo
ABBV
(NYSE)
AbbVie Inc.
$208.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AbbVie (ABBV) Stock Price & Financial Analysis

AbbVie Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$207.71 - $214.56
52-Week High$244.81
52-Week Low$164.39
Open$213.99
Volume5.06M
Average Volume (3M)5.06M
Market Cap373.97B
Shares Outstanding1.79B
P/E Ratio (TTM)91.09
Forward P/E91.35
Price to Sales (P/S)6.29
EV/EBITDA15.86
Revenue (TTM)61.16B
Net Income (TTM)4.23B
Free Cash Flow (TTM)17.82B
EPS (TTM)$2.38
Profit Margin6.91%
Operating Margin32.85%
50-Day MA$221.75
200-Day MA$216.07
52-Week Change4.22%
Annual Dividend$6.65
Dividend Yield3.09%
Payout Ratio279.15%
Last Dividend Ex-DateApr 15, 2026

Frequently Asked Questions About AbbVie

What is the current stock price for ABBV?

As of the latest trading session, ABBV stock trades at $208.84. The 52-week range is $164.39–$244.81, with a day range of $207.71–$214.56.

What is the P/E ratio for ABBV?

AbbVie's trailing P/E ratio is 91.1, meaning investors pay $91.1 for every $1 of annual earnings. The forward P/E is 91.3, reflecting analyst expectations for future earnings. AbbVie operates in the Healthcare sector.

Does ABBV pay dividends?

Yes, AbbVie pays a 3.09% annual dividend yield ($6.65 per share). The payout ratio is 279.1%. The last ex-dividend date was 2026-04-15.

What do analysts recommend for ABBV?

Based on 27 analysts, the consensus for ABBV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABBV?

AbbVie's market capitalization is $373.97B, classifying it as a mega-cap company. AbbVie operates in the Healthcare sector within the Drug Manufacturers - General industry.